Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HUANG, Xiaoquan
PLAEGV, NCT04524676: Oxaliplatin-induced Portal Hypertension	Not yet recruiting	N/A	25	RoW	Individualized Treatment	Shanghai Zhongshan Hospital	Gastroesophageal Varices Hemorrhage, Colorectal Cancer, Received Oxaliplatin-based Chemotherapy	10/21	09/22
PLAEGV-TRE, NCT05141617: Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding	Recruiting	N/A	100	RoW	Endoscopic treatment, TIPS	Shanghai Zhongshan Hospital, First Affiliated Hospital of Wenzhou Medical University, Shanghai Minhang Central Hospital, Anhui Provincial Hospital	Gastroesophageal Varices Hemorrhage, Gastrointestinal Cancer, Received Oxaliplatin-based Chemotherapy	12/23	12/23
NCT04525768: Gastroesophageal Varices in Cavernoma	Not yet recruiting	N/A	80	RoW	JAK2 mutation test	Shanghai Zhongshan Hospital	Gastroesophageal Varices, Myeloproliferative Neoplasm, Portal Caver Cavernoma, Portal Hypertension	09/21	09/22